TMI-1
TMI-1 (WAY-171318), a novel orally active inhibitor of ADAM17 (TACE) and MMP, induces tumor apoptosis in a breast cancer.
Product Specifications
CAS Number
287403-39-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
398.5
Molecular Formula
C17H22N2O5S2
Notes
Research use only, not for human use.
Receptor
Apoptosis | MMP
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx307117-01 20 µg
Squamous Cell Carcinoma Antigen Recognized By T-Cells 3 (SART3) Antibody (FITC)
Ask
View Details 
abx307117-02 50 µg
Squamous Cell Carcinoma Antigen Recognized By T-Cells 3 (SART3) Antibody (FITC)
Ask
View Details abx307117-03 100 µg
Squamous Cell Carcinoma Antigen Recognized By T-Cells 3 (SART3) Antibody (FITC)
Ask
View Details 
abx307117-04 200 µg
Squamous Cell Carcinoma Antigen Recognized By T-Cells 3 (SART3) Antibody (FITC)
Ask
View Details abx307117-05 1 mg
Squamous Cell Carcinoma Antigen Recognized By T-Cells 3 (SART3) Antibody (FITC)
Ask
View Details